THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis
FRA:TN8 - Deutsche Boerse Ag - US8835561023 - Common Stock - Currency: EUR
TN8 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. TN8 scores excellent on profitability, but there are some minor concerns on its financial health. TN8 is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TN8 was profitable.
TN8 had a positive operating cash flow in the past year.
TN8 had positive earnings in each of the past 5 years.
In the past 5 years TN8 always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 6.50%, TN8 belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
TN8 has a better Return On Equity (13.04%) than 94.44% of its industry peers.
With a decent Return On Invested Capital value of 6.25%, TN8 is doing good in the industry, outperforming 61.11% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for TN8 is in line with the industry average of 6.95%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROIC | 6.25% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
1.3 Margins
The Profit Margin of TN8 (15.24%) is better than 94.44% of its industry peers.
TN8's Profit Margin has been stable in the last couple of years.
The Operating Margin of TN8 (18.18%) is better than 72.22% of its industry peers.
TN8's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 41.34%, TN8 perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Gross Margin of TN8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% |
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TN8 is destroying value.
TN8 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TN8 has been reduced compared to 5 years ago.
Compared to 1 year ago, TN8 has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of TN8 is 5.71, which is a neutral value as it means it would take TN8, 5.71 years of fcf income to pay off all of its debts.
TN8's Debt to FCF ratio of 5.71 is in line compared to the rest of the industry. TN8 outperforms 44.44% of its industry peers.
TN8 has a Debt/Equity ratio of 0.65. This is a neutral value indicating TN8 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, TN8 is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Altman-Z | N/A |
ROIC/WACC0.64
WACC9.83%
2.3 Liquidity
TN8 has a Current Ratio of 1.93. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
TN8 has a Current ratio of 1.93. This is in the better half of the industry: TN8 outperforms 77.78% of its industry peers.
TN8 has a Quick Ratio of 1.50. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TN8 (1.50) is better than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
TN8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.23%.
TN8 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.12% yearly.
Looking at the last year, TN8 shows a small growth in Revenue. The Revenue has grown by 2.05% in the last year.
Measured over the past years, TN8 shows a quite strong growth in Revenue. The Revenue has been growing by 10.92% on average per year.
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
3.2 Future
The Earnings Per Share is expected to grow by 8.79% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.89% on average over the next years.
EPS Next Y3.18%
EPS Next 2Y6.76%
EPS Next 3Y8.41%
EPS Next 5Y8.79%
Revenue Next Year2.49%
Revenue Next 2Y3.65%
Revenue Next 3Y4.39%
Revenue Next 5Y4.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.68, which indicates a rather expensive current valuation of TN8.
Compared to the rest of the industry, the Price/Earnings ratio of TN8 indicates a somewhat cheap valuation: TN8 is cheaper than 77.78% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of TN8 to the average of the S&P500 Index (26.54), we can say TN8 is valued slightly cheaper.
A Price/Forward Earnings ratio of 18.17 indicates a rather expensive valuation of TN8.
TN8's Price/Forward Earnings ratio is rather cheap when compared to the industry. TN8 is cheaper than 88.89% of the companies in the same industry.
TN8 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.28, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.68 | ||
| Fwd PE | 18.17 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TN8 is on the same level as its industry peers.
TN8's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.7 | ||
| EV/EBITDA | 18.45 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.5
PEG (5Y)1.71
EPS Next 2Y6.76%
EPS Next 3Y8.41%
5. Dividend
5.1 Amount
TN8 has a yearly dividend return of 0.37%, which is pretty low.
Compared to an average industry Dividend Yield of 0.73, TN8 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.40, TN8's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
5.2 History
The dividend of TN8 is nicely growing with an annual growth rate of 15.37%!
Dividend Growth(5Y)15.37%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
TN8 pays out 9.26% of its income as dividend. This is a sustainable payout ratio.
TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.26%
EPS Next 2Y6.76%
EPS Next 3Y8.41%
FRA:TN8 (8/7/2025, 7:00:00 PM)
388.85
-3.75 (-0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.22%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap146.79B
Analysts81.14
Price Target485.35 (24.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
Yearly Dividend1.33
Dividend Growth(5Y)15.37%
DP9.26%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)0.72%
Min EPS beat(4)-0.34%
Max EPS beat(4)1.69%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)7
Avg EPS beat(12)1.2%
EPS beat(16)11
Avg EPS beat(16)5.31%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.28%
Max Revenue beat(2)0.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.62%
Revenue beat(8)5
Avg Revenue beat(8)-0.15%
Revenue beat(12)7
Avg Revenue beat(12)0.84%
Revenue beat(16)11
Avg Revenue beat(16)3.32%
PT rev (1m)-1.47%
PT rev (3m)-12.69%
EPS NQ rev (1m)-0.41%
EPS NQ rev (3m)-4.79%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-3.95%
Revenue NQ rev (1m)0.45%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.68 | ||
| Fwd PE | 18.17 | ||
| P/S | 3.96 | ||
| P/FCF | 27.7 | ||
| P/OCF | 22.55 | ||
| P/B | 3.39 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.45 |
EPS(TTM)18.8
EY4.83%
EPS(NY)21.4
Fwd EY5.5%
FCF(TTM)14.04
FCFY3.61%
OCF(TTM)17.24
OCFY4.43%
SpS98.32
BVpS114.85
TBVpS-27.12
PEG (NY)6.5
PEG (5Y)1.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROCE | 8.88% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 28.04% | ||
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% | ||
| FCFM | 14.28% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Debt/EBITDA | 3.08 | ||
| Cap/Depr | 49.03% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 70.63% | ||
| Profit Quality | 93.71% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | N/A |
F-Score7
WACC9.83%
ROIC/WACC0.64
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
EPS Next Y3.18%
EPS Next 2Y6.76%
EPS Next 3Y8.41%
EPS Next 5Y8.79%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
Revenue Next Year2.49%
Revenue Next 2Y3.65%
Revenue Next 3Y4.39%
Revenue Next 5Y4.89%
EBIT growth 1Y5.17%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year12.01%
EBIT Next 3Y9.78%
EBIT Next 5Y8.38%
FCF growth 1Y5.4%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-1.49%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%